Epigenomics and Breast Cancer
- 15 December 2008
- journal article
- review article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 9 (12) , 1879-1902
- https://doi.org/10.2217/14622416.9.12.1879
Abstract
Breast carcinogenesis involves genetic and epigenetic alterations that cause aberrant gene function. Recent progress in the knowledge of epigenomics has had a profound impact on the understanding of mechanisms leading to breast cancer, and consequently the development of new strategies for diagnosis and treatment of breast cancer. Epigenetic regulation has been known to involve three mutually interacting events – DNA methylation, histone modifications and nucleosomal remodeling. These processes modulate chromatin structure to form euchromatin or heterochromatin, and in turn activate or silence gene expression. Alteration in expression of key genes through aberrant epigenetic regulation in breast cells can lead to initiation, promotion and maintenance of carcinogenesis, and is even implicated in the generation of drug resistance. We currently review known roles of the epigenetic machinery in the development and recurrence of breast cancer. Furthermore, we highlight the significance of epigenetic alteration...Keywords
Funding Information
- Oncomethylome Sciences Inc.
This publication has 212 references indexed in Scilit:
- Methyl-CpG binding proteins: specialized transcriptional repressors or structural components of chromatin?Cellular and Molecular Life Sciences, 2008
- Epigenetic inactivation of microRNA gene hsa‐mir‐9‐1 in human breast cancerThe Journal of Pathology, 2007
- High-Resolution Profiling of Histone Methylations in the Human GenomePublished by Elsevier ,2007
- Genome Regulation by Polycomb and Trithorax ProteinsPublished by Elsevier ,2007
- The Epigenomics of CancerPublished by Elsevier ,2007
- The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3Published by Elsevier ,2004
- DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociationNature, 2003
- Aberrant CpG-island methylation has non-random and tumour-type–specific patternsNature Genetics, 2000
- The Hallmarks of CancerCell, 2000
- Identification of a mammalian protein that binds specifically to DNA containing methylated CpGsPublished by Elsevier ,1989